Cargando…

Actin stress fiber organization promotes cell stiffening and proliferation of pre-invasive breast cancer cells

Studies of the role of actin in tumour progression have highlighted its key contribution in cell softening associated with cell invasion. Here, using a human breast cell line with conditional Src induction, we demonstrate that cells undergo a stiffening state prior to acquiring malignant features. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavares, Sandra, Vieira, André Filipe, Taubenberger, Anna Verena, Araújo, Margarida, Martins, Nuno Pimpao, Brás-Pereira, Catarina, Polónia, António, Herbig, Maik, Barreto, Clara, Otto, Oliver, Cardoso, Joana, Pereira-Leal, José B., Guck, Jochen, Paredes, Joana, Janody, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440822/
https://www.ncbi.nlm.nih.gov/pubmed/28508872
http://dx.doi.org/10.1038/ncomms15237
Descripción
Sumario:Studies of the role of actin in tumour progression have highlighted its key contribution in cell softening associated with cell invasion. Here, using a human breast cell line with conditional Src induction, we demonstrate that cells undergo a stiffening state prior to acquiring malignant features. This state is characterized by the transient accumulation of stress fibres and upregulation of Ena/VASP-like (EVL). EVL, in turn, organizes stress fibres leading to transient cell stiffening, ERK-dependent cell proliferation, as well as enhancement of Src activation and progression towards a fully transformed state. Accordingly, EVL accumulates predominantly in premalignant breast lesions and is required for Src-induced epithelial overgrowth in Drosophila. While cell softening allows for cancer cell invasion, our work reveals that stress fibre-mediated cell stiffening could drive tumour growth during premalignant stages. A careful consideration of the mechanical properties of tumour cells could therefore offer new avenues of exploration when designing cancer-targeting therapies.